Richard P.
Richard studied Chemical Engineering at the University of Auckland, and subsequently received his PhD in Materials Science from MIT. He currently works as a technology investor at a venture capital firm.
Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Elliot
Elliot earned his BS in Biology at MIT, and his MSc by Research in Clinical Medicine on a Rhodes Scholarshop at Oxford University. Currently, he is an MD/PhD student in the the Harvard-MIT Health Sciences and Technology program.